Werewolf Therapeutics Inc

Werewolf Therapeutics Insider Signals Bullish Outlook as VP Holds Options Despite Stock Slump

Investors eye Werewolf Therapeutics as VP of Finance holds vested stock options, signaling bullish confidence amid share price lows and potential strategic deals.

Werewolf Therapeutics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

13/03/2026, 21:29

3 minutes to read

Werewolf Therapeutics Insider Sell‑Off: 43k Shares at Market Price—What It Means for Investors

Werewolf Therapeutics insider sale: Director EVNIN LUKE sells 43k+ shares at $0.55, a planned 10b5‑1 exit that may signal confidence issues amid a 49% stock drop.

Werewolf Therapeutics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

15/01/2026, 23:38

3 minutes to read